深圳欣博盛生物科技有限公司

PepMix SARS-CoV (Nucleoprotein)

Pool of 103 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (Swiss-Prot ID: P59595) of SARS-CoV (Severe acute respiratory syndrome coronavirus).PepMix™ SARS-CoV (Nucleoprotein) - SpecificationsAmount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) - (equivalent to an average purity of 85%)Delivery Format: Freeze-dried in glass vialApplication(s): Condition(s)/Topic(s): Infection, Respiratory infectionStandard Delivery Time: 2-5 daysPepMix™ Peptide PoolsProtein-spanning mixtures of overlapping peptides (PepMix™) are extremely efficient for- Antigen-specific T cell stimulation in T cell assays (e.g. in ELISpot, ICS, cell-mediated cytotoxicity or proliferation assays)- In-vitro T cell expansion- Dendritic cell pulsing- Immune monitoring- Cellular immune response profiling- T cell epitope identification- Standardization of T cell assaysBenefits of PepMix™- Each peptide quality controlled and guaranteed for identity and purity- CoA and HPLC-MS data available- High batch-to-batch consistency- No false positive T cell responses by contaminating deletion peptides- No toxic inhibition of T cell responses due to stringent purification of each peptide- Minimization of endotoxin contamination due to low bioburden process- ADCF policy in place- HLA independent stimulation (with antigen spanning peptide pools)

德国

JPT Peptide Technologies